Lv45
750 积分 2023-04-18 加入
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
1天前
已完结
Incidental findings in research: A focus group study about the perspective of the research participant
2天前
已完结
Effect of Semaglutide on Kidney Outcomes in People With Overweight or Obesity and Established Cardiovascular Disease in the SELECT Trial
2天前
求助中
GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management
8天前
已完结
Consequences of Rapid Weight Loss
8天前
已完结
Adipose Tissue and Adipokines in Health and Disease - Consequences of Rapid Weight Loss
8天前
已关闭
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
14天前
已完结
Obesity-induced and weight-loss-induced physiological factors affecting weight regain
14天前
已完结
The role of appetite-related hormones, adaptive thermogenesis, perceived hunger and stress in long-term weight-loss maintenance: a mixed-methods study
14天前
已完结
Weight Stigma and Barriers to Effective Obesity Care
15天前
已关闭
皖公网安备34019202002308
